Cargando…
Embryonic Cardiomyocyte, but Not Autologous Stem Cell Transplantation, Restricts Infarct Expansion, Enhances Ventricular Function, and Improves Long-Term Survival
AIMS: Controversy exists in regard to the beneficial effects of transplanting cardiac or somatic progenitor cells upon myocardial injury. We have therefore investigated the functional short- and long-term consequences after intramyocardial transplantation of these cell types in a murine lesion model...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3621863/ https://www.ncbi.nlm.nih.gov/pubmed/23585908 http://dx.doi.org/10.1371/journal.pone.0061510 |
_version_ | 1782265775733604352 |
---|---|
author | Paulis, Leonie E. Klein, Alexandra M. Ghanem, Alexander Geelen, Tessa Coolen, Bram F. Breitbach, Martin Zimmermann, Katrin Nicolay, Klaas Fleischmann, Bernd K. Roell, Wilhelm Strijkers, Gustav J. |
author_facet | Paulis, Leonie E. Klein, Alexandra M. Ghanem, Alexander Geelen, Tessa Coolen, Bram F. Breitbach, Martin Zimmermann, Katrin Nicolay, Klaas Fleischmann, Bernd K. Roell, Wilhelm Strijkers, Gustav J. |
author_sort | Paulis, Leonie E. |
collection | PubMed |
description | AIMS: Controversy exists in regard to the beneficial effects of transplanting cardiac or somatic progenitor cells upon myocardial injury. We have therefore investigated the functional short- and long-term consequences after intramyocardial transplantation of these cell types in a murine lesion model. METHODS AND RESULTS: Myocardial infarction (MI) was induced in mice (n = 75), followed by the intramyocardial injection of 1−2×10(5) luciferase- and GFP-expressing embryonic cardiomyocytes (eCMs), skeletal myoblasts (SMs), mesenchymal stem cells (MSCs) or medium into the infarct. Non-treated healthy mice (n = 6) served as controls. Bioluminescence and fluorescence imaging confirmed the engraftment and survival of the cells up to seven weeks postoperatively. After two weeks MRI was performed, which showed that infarct volume was significantly decreased by eCMs only (14.8±2.2% MI+eCM vs. 26.7±1.6% MI). Left ventricular dilation was significantly decreased by transplantation of any cell type, but most efficiently by eCMs. Moreover, eCM treatment increased the ejection fraction and cardiac output significantly to 33.4±2.2% and 22.3±1.2 ml/min. In addition, this cell type exclusively and significantly increased the end-systolic wall thickness in the infarct center and borders and raised the wall thickening in the infarct borders. Repetitive echocardiography examinations at later time points confirmed that these beneficial effects were accompanied by better survival rates. CONCLUSION: Cellular cardiomyoplasty employing contractile and electrically coupling embryonic cardiomyocytes (eCMs) into ischemic myocardium provoked significantly smaller infarcts with less adverse remodeling and improved cardiac function and long-term survival compared to transplantation of somatic cells (SMs and MSCs), thereby proving that a cardiomyocyte phenotype is important to restore myocardial function. |
format | Online Article Text |
id | pubmed-3621863 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-36218632013-04-12 Embryonic Cardiomyocyte, but Not Autologous Stem Cell Transplantation, Restricts Infarct Expansion, Enhances Ventricular Function, and Improves Long-Term Survival Paulis, Leonie E. Klein, Alexandra M. Ghanem, Alexander Geelen, Tessa Coolen, Bram F. Breitbach, Martin Zimmermann, Katrin Nicolay, Klaas Fleischmann, Bernd K. Roell, Wilhelm Strijkers, Gustav J. PLoS One Research Article AIMS: Controversy exists in regard to the beneficial effects of transplanting cardiac or somatic progenitor cells upon myocardial injury. We have therefore investigated the functional short- and long-term consequences after intramyocardial transplantation of these cell types in a murine lesion model. METHODS AND RESULTS: Myocardial infarction (MI) was induced in mice (n = 75), followed by the intramyocardial injection of 1−2×10(5) luciferase- and GFP-expressing embryonic cardiomyocytes (eCMs), skeletal myoblasts (SMs), mesenchymal stem cells (MSCs) or medium into the infarct. Non-treated healthy mice (n = 6) served as controls. Bioluminescence and fluorescence imaging confirmed the engraftment and survival of the cells up to seven weeks postoperatively. After two weeks MRI was performed, which showed that infarct volume was significantly decreased by eCMs only (14.8±2.2% MI+eCM vs. 26.7±1.6% MI). Left ventricular dilation was significantly decreased by transplantation of any cell type, but most efficiently by eCMs. Moreover, eCM treatment increased the ejection fraction and cardiac output significantly to 33.4±2.2% and 22.3±1.2 ml/min. In addition, this cell type exclusively and significantly increased the end-systolic wall thickness in the infarct center and borders and raised the wall thickening in the infarct borders. Repetitive echocardiography examinations at later time points confirmed that these beneficial effects were accompanied by better survival rates. CONCLUSION: Cellular cardiomyoplasty employing contractile and electrically coupling embryonic cardiomyocytes (eCMs) into ischemic myocardium provoked significantly smaller infarcts with less adverse remodeling and improved cardiac function and long-term survival compared to transplantation of somatic cells (SMs and MSCs), thereby proving that a cardiomyocyte phenotype is important to restore myocardial function. Public Library of Science 2013-04-09 /pmc/articles/PMC3621863/ /pubmed/23585908 http://dx.doi.org/10.1371/journal.pone.0061510 Text en © 2013 Paulis et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Paulis, Leonie E. Klein, Alexandra M. Ghanem, Alexander Geelen, Tessa Coolen, Bram F. Breitbach, Martin Zimmermann, Katrin Nicolay, Klaas Fleischmann, Bernd K. Roell, Wilhelm Strijkers, Gustav J. Embryonic Cardiomyocyte, but Not Autologous Stem Cell Transplantation, Restricts Infarct Expansion, Enhances Ventricular Function, and Improves Long-Term Survival |
title | Embryonic Cardiomyocyte, but Not Autologous Stem Cell Transplantation, Restricts Infarct Expansion, Enhances Ventricular Function, and Improves Long-Term Survival |
title_full | Embryonic Cardiomyocyte, but Not Autologous Stem Cell Transplantation, Restricts Infarct Expansion, Enhances Ventricular Function, and Improves Long-Term Survival |
title_fullStr | Embryonic Cardiomyocyte, but Not Autologous Stem Cell Transplantation, Restricts Infarct Expansion, Enhances Ventricular Function, and Improves Long-Term Survival |
title_full_unstemmed | Embryonic Cardiomyocyte, but Not Autologous Stem Cell Transplantation, Restricts Infarct Expansion, Enhances Ventricular Function, and Improves Long-Term Survival |
title_short | Embryonic Cardiomyocyte, but Not Autologous Stem Cell Transplantation, Restricts Infarct Expansion, Enhances Ventricular Function, and Improves Long-Term Survival |
title_sort | embryonic cardiomyocyte, but not autologous stem cell transplantation, restricts infarct expansion, enhances ventricular function, and improves long-term survival |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3621863/ https://www.ncbi.nlm.nih.gov/pubmed/23585908 http://dx.doi.org/10.1371/journal.pone.0061510 |
work_keys_str_mv | AT paulisleoniee embryoniccardiomyocytebutnotautologousstemcelltransplantationrestrictsinfarctexpansionenhancesventricularfunctionandimproveslongtermsurvival AT kleinalexandram embryoniccardiomyocytebutnotautologousstemcelltransplantationrestrictsinfarctexpansionenhancesventricularfunctionandimproveslongtermsurvival AT ghanemalexander embryoniccardiomyocytebutnotautologousstemcelltransplantationrestrictsinfarctexpansionenhancesventricularfunctionandimproveslongtermsurvival AT geelentessa embryoniccardiomyocytebutnotautologousstemcelltransplantationrestrictsinfarctexpansionenhancesventricularfunctionandimproveslongtermsurvival AT coolenbramf embryoniccardiomyocytebutnotautologousstemcelltransplantationrestrictsinfarctexpansionenhancesventricularfunctionandimproveslongtermsurvival AT breitbachmartin embryoniccardiomyocytebutnotautologousstemcelltransplantationrestrictsinfarctexpansionenhancesventricularfunctionandimproveslongtermsurvival AT zimmermannkatrin embryoniccardiomyocytebutnotautologousstemcelltransplantationrestrictsinfarctexpansionenhancesventricularfunctionandimproveslongtermsurvival AT nicolayklaas embryoniccardiomyocytebutnotautologousstemcelltransplantationrestrictsinfarctexpansionenhancesventricularfunctionandimproveslongtermsurvival AT fleischmannberndk embryoniccardiomyocytebutnotautologousstemcelltransplantationrestrictsinfarctexpansionenhancesventricularfunctionandimproveslongtermsurvival AT roellwilhelm embryoniccardiomyocytebutnotautologousstemcelltransplantationrestrictsinfarctexpansionenhancesventricularfunctionandimproveslongtermsurvival AT strijkersgustavj embryoniccardiomyocytebutnotautologousstemcelltransplantationrestrictsinfarctexpansionenhancesventricularfunctionandimproveslongtermsurvival |